共 167 条
[1]
Kinloch RA(2005)New targets for neuropathic pain therapeutics Expert Opin Ther Targets 9 685-698
[2]
Cox PJ(2020)Development of multitarget inhibitors for the treatment of pain: design, synthesis, biological evaluation and molecular modeling studies Bioorg Chem 103 425-434
[3]
Wilt S(2012)A series of case studies: practical methodology for identifying anti-nociceptive multi-target drugs Drug Discov Today 17 28-632
[4]
Kodani S(2014)Targeting the endogenous cannabinoid system to treat neuropathic pain Front Pharmacol 5 624-328
[5]
Le TNH(2007)Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain Br J Pharmacol 152 323-281
[6]
Nguyen L(2022)Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and anti-nociceptive activities of 4-methylsulfonylaniline-derived semicarbazones Bioorg Med Chem 60 277-8069
[7]
Vo N(1998)Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity Brain Res 813 1423-422
[8]
Ly T(1998)Control of pain initiation by endogenous cannabinoids Nature 394 1744-1623
[9]
Pang M-H(2020)Targeting peripherally restricted cannabinoid receptor 1, cannabinoid receptor 2, and endocannabinoid-degrading enzymes for the treatment of neuropathic pain including neuropathic orofacial pain Int J Mol Sci 21 415-1387
[10]
Kim Y(2009)Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain Mol Pain 5 1611-2632